PURA VIDA INVESTMENTS, LLC - Q2 2021 holdings

Add to watchlist

$3.21 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 216 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 63.4% .

All

			Value		Shares		↓ Weighting
ESTA	Sell	ESTABLISHMENT LABS HLDGS INC	$91,469,000	+32.9%	1,047,275	-4.9%	2.85%	+45.1%
INOV	Sell	INOVALON HLDGS INC	$54,697,000	+15.3%	1,604,973	-2.6%	1.70%	+25.9%
ATRC	Sell	ATRICURE INC	$44,851,000	+11.1%	565,370	-8.2%	1.40%	+21.4%
INSP	Sell	INSPIRE MED SYS INC	$39,424,000	-6.7%	203,996	-0.1%	1.23%	+1.9%
STAA	Sell	STAAR SURGICAL CO	$26,957,000	-11.0%	176,769	-38.5%	0.84%	-2.8%
NTRA	Sell	NATERA INC	$24,615,000	-2.1%	216,816	-12.4%	0.77%	+6.8%
HYFM	Sell	HYDROFARM HLDGS GROUP INC	$22,921,000	-15.2%	387,774	-13.5%	0.71%	-7.5%
ORGO	Sell	ORGANOGENESIS HLDGS INC	$21,300,000	-22.5%	1,281,600	-15.0%	0.66%	-15.3%
APR	Sell	APRIA INC	$19,592,000	-8.5%	699,720	-8.7%	0.61%	0.0%
LIVN	Sell	LIVANOVA PLC	$19,380,000	+4.1%	230,413	-8.7%	0.60%	+13.8%
MDVL	Sell	MEDAVAIL HOLDINGS INC	$16,689,000	-47.2%	1,362,384	-41.8%	0.52%	-42.4%
PACB	Sell	PACIFIC BIOSCIENCES CALIF IN	$16,498,000	-15.6%	471,777	-19.6%	0.51%	-7.9%
STXS	Sell	STEREOTAXIS INC	$14,001,000	+28.1%	1,452,346	-10.7%	0.44%	+40.2%
SDGR	Sell	SCHRODINGER INC	$13,466,000	-2.3%	178,099	-1.4%	0.42%	+6.6%
TXG	Sell	10X GENOMICS INC	$12,657,000	-1.1%	64,637	-8.6%	0.39%	+7.9%
PSNL	Sell	PERSONALIS INC	$12,018,000	-10.9%	475,008	-13.3%	0.37%	-2.6%
DXCM	Sell	DEXCOM INC	$11,238,000	+16.9%	26,319	-1.6%	0.35%	+27.7%
IVC	Sell	INVACARE CORP	$10,983,000	-25.1%	1,360,955	-25.6%	0.34%	-18.2%
PROF	Sell	PROFOUND MED CORP	$10,540,000	-32.2%	644,273	-16.5%	0.33%	-26.0%
MSON	Sell	MISONIX INC	$10,474,000	+5.9%	472,216	-6.4%	0.33%	+15.6%
OLK	Sell	OLINK HLDG ABsponsored ads	$10,026,000	-25.4%	291,278	-22.0%	0.31%	-18.5%
APYX	Sell	APYX MEDICAL CORPORATION	$9,816,000	+6.0%	952,045	-0.7%	0.31%	+15.9%
BVS	Sell	BIOVENTUS INC	$9,584,000	-28.5%	544,545	-37.9%	0.30%	-22.0%
XENT	Sell	INTERSECT ENT INC	$9,079,000	-52.2%	531,229	-41.6%	0.28%	-47.7%
SEER	Sell	SEER INC	$8,295,000	-36.7%	253,041	-3.4%	0.26%	-30.8%
GH	Sell	GUARDANT HEALTH INC	$8,226,000	-48.1%	66,240	-36.3%	0.26%	-43.4%
ZBH	Sell	ZIMMER BIOMET HOLDINGS INC	$8,041,000	-49.2%	50,000	-49.5%	0.25%	-44.6%
ARYD	Sell	ARYA SCIENCES ACQU CORP IVcl a	$5,737,000	+0.7%	535,179	-1.7%	0.18%	+10.5%
ICAD	Sell	ICAD INC	$5,371,000	-34.8%	310,278	-20.1%	0.17%	-28.9%
RCEL	Sell	AVITA MEDICAL INC	$5,314,000	-30.1%	258,951	-32.5%	0.16%	-24.0%
RACB	Sell	RESEARCH ALLIANCE CORP II	$5,275,000	-3.5%	520,180	-2.5%	0.16%	+5.1%
GKOS	Sell	GLAUKOS CORP	$4,666,000	-39.9%	55,000	-40.5%	0.14%	-34.4%
TPB	Sell	TURNING PT BRANDS INC	$4,625,000	-59.2%	101,059	-53.5%	0.14%	-55.4%
IMGN	Sell	IMMUNOGEN INC	$4,541,000	-30.3%	689,049	-14.3%	0.14%	-24.2%
CLDX	Sell	CELLDEX THERAPEUTICS INC NEW	$3,513,000	+4.2%	105,056	-35.8%	0.11%	+13.5%
ARQT	Sell	ARCUTIS BIOTHERAPEUTICS INC	$3,113,000	-26.2%	114,061	-21.7%	0.10%	-19.2%
ARVN	Sell	ARVINAS INC	$2,429,000	+14.8%	31,543	-1.5%	0.08%	+26.7%
ABGI	Sell	ABG ACQUISITION CORP I	$2,379,000	-2.4%	242,770	-1.5%	0.07%	+7.2%
FBRX	Sell	FORTE BIOSCIENCES INC	$2,205,000	-43.3%	65,583	-42.2%	0.07%	-37.8%
FVAM	Sell	5 01 ACQUISITION CORP	$2,152,000	-1.3%	215,836	-1.5%	0.07%	+8.1%
FRONU	Sell	FRONTIER ACQUISITION CORPunit 03/01/2026	$2,167,000	-27.3%	216,708	-27.8%	0.07%	-21.2%
VERO	Sell	VENUS CONCEPT INC	$2,136,000	+29.6%	686,874	-2.1%	0.07%	+40.4%
KURA	Sell	KURA ONCOLOGY INC	$2,082,000	-40.7%	99,862	-19.6%	0.06%	-35.0%
RPTX	Sell	REPARE THERAPEUTICS INC	$1,599,000	-2.9%	51,271	-4.4%	0.05%	+6.4%
PMGMU	Sell	PRIVETERRA ACQUISITION CORPunit 99/99/9999	$1,608,000	-23.5%	161,472	-23.6%	0.05%	-16.7%
PHAT	Sell	PHATHOM PHARMACEUTICALS INC	$1,530,000	-36.1%	45,211	-29.1%	0.05%	-29.4%
TVTX	Sell	TRAVERE THERAPEUTICS INC	$1,538,000	-51.3%	105,382	-16.7%	0.05%	-46.7%
PSTX	Sell	POSEIDA THERAPEUTICS INC	$1,434,000	-36.5%	143,120	-39.4%	0.04%	-29.7%
SRRA	Sell	SIERRA ONCOLOGY INC	$1,460,000	+9.7%	74,967	-3.0%	0.04%	+18.4%
AVDL	Sell	AVADEL PHARMACEUTICALS PLCsponsored adr	$1,186,000	-44.0%	176,206	-24.7%	0.04%	-38.3%
EPIX	Sell	ESSA PHARMA INC	$1,109,000	-71.2%	38,803	-70.7%	0.04%	-68.2%
LOGC	Sell	LOGICBIO THERAPEUTICS INC	$1,107,000	-39.9%	249,256	-1.5%	0.03%	-35.8%
HSAQ	Sell	HEALTH SCIENCES ACQ CORP 2	$1,101,000	-10.1%	107,918	-1.4%	0.03%	-2.9%
MTACU	Sell	MEDTECH ACQUISITION CORPunit 12/18/2025	$1,042,000	-64.3%	103,944	-64.2%	0.03%	-61.4%
FNCH	Sell	FINCH THERAPEUTICS GROUP INC	$1,007,000	-61.0%	71,552	-55.3%	0.03%	-58.1%
HCAQ	Sell	HEALTHCOR CATALIO ACQU CORP	$958,000	-2.4%	97,217	-1.0%	0.03%	+7.1%
CYCC	Sell	CYCLACEL PHARMACEUTICALS INC	$931,000	-52.2%	157,334	-42.6%	0.03%	-48.2%
EXEL	Sell	EXELIXIS INC	$943,000	-37.2%	51,779	-22.1%	0.03%	-32.6%
YMTX	Sell	YUMANITY THERAPEUTICS INC	$794,000	-36.3%	68,197	-1.0%	0.02%	-30.6%
GOSS	Sell	GOSSAMER BIO INC	$801,000	-13.6%	98,633	-1.6%	0.02%	-3.8%
ACHL	Sell	ACHILLES THERAPEUTICS PLCsponsored ads	$794,000	-53.4%	81,126	-21.3%	0.02%	-49.0%
SPKBU	Sell	SILVER SPIKE ACQUISITN CORPunit 02/26/2026	$783,000	-83.4%	77,505	-83.7%	0.02%	-82.2%
XGN	Sell	EXAGEN INC	$772,000	-86.7%	51,502	-84.4%	0.02%	-85.5%
CTMX	Sell	CYTOMX THERAPEUTICS INC	$638,000	-59.2%	100,841	-50.2%	0.02%	-55.6%
KALV	Sell	KALVISTA PHARMACEUTICALS INC	$478,000	-8.1%	19,956	-1.5%	0.02%	0.0%
SNSE	Sell	SENSEI BIOTHERAPEUTICS INC	$208,000	-77.9%	22,603	-66.4%	0.01%	-77.8%
SVRA	Sell	SAVARA INC	$169,000	-18.8%	99,448	-0.6%	0.01%	-16.7%
IDRA	Exit	IDERA PHARMACEUTICALS INCcall	$0	–	-160,000	-100.0%	-0.01%	–
NKTX	Exit	NKARTA INC	$0	–	-7,919	-100.0%	-0.01%	–
INO	Exit	INOVIO PHARMACEUTICALS INCput	$0	–	-32,300	-100.0%	-0.01%	–
SSPKW	Exit	SILVER SPIKE ACQUISITION COR*w exp 08/02/202	$0	–	-50,000	-100.0%	-0.01%	–
OCUP	Exit	OCUPHIRE PHARMA INC	$0	–	-57,536	-100.0%	-0.01%	–
IDRA	Exit	IDERA PHARMACEUTICALS INCput	$0	–	-333,800	-100.0%	-0.01%	–
FOLD	Exit	AMICUS THERAPEUTICS INC	$0	–	-45,525	-100.0%	-0.01%	–
BCAB	Exit	BIOATLA INC	$0	–	-8,995	-100.0%	-0.01%	–
CMLFW	Exit	CM LIFE SCIENCES INC*w exp 09/04/202	$0	–	-101,416	-100.0%	-0.02%	–
SLDB	Exit	SOLID BIOSCIENCES INCcall	$0	–	-100,000	-100.0%	-0.02%	–
HECCW	Exit	HUDSON EXECUTIVE INVT CORP*w exp 06/21/202	$0	–	-454,718	-100.0%	-0.02%	–
AUPH	Exit	AURINIA PHARMACEUTICALS INC	$0	–	-50,575	-100.0%	-0.02%	–
VAPO	Exit	VAPOTHERM INCput	$0	–	-29,800	-100.0%	-0.02%	–
LVTX	Exit	LAVA THERAPEUTICS NV	$0	–	-54,000	-100.0%	-0.02%	–
FREQ	Exit	FREQUENCY THERAPEUTICS INC	$0	–	-100,000	-100.0%	-0.03%	–
FREQ	Exit	FREQUENCY THERAPEUTICS INCcall	$0	–	-100,000	-100.0%	-0.03%	–
FOLD	Exit	AMICUS THERAPEUTICS INCput	$0	–	-101,300	-100.0%	-0.03%	–
DTIL	Exit	PRECISION BIOSCIENCES INC	$0	–	-101,104	-100.0%	-0.03%	–
AGTC	Exit	APPLIED GENETIC TECHNOLOGIES	$0	–	-206,423	-100.0%	-0.03%	–
CMPS	Exit	COMPASS PATHWAYS PLCcall	$0	–	-30,000	-100.0%	-0.03%	–
CAPA	Exit	HIGHCAPE CAP ACQUISITION COR	$0	–	-115,477	-100.0%	-0.04%	–
ONCR	Exit	ONCORUS INC	$0	–	-101,264	-100.0%	-0.04%	–
ALPN	Exit	ALPINE IMMUNE SCIENCES INC	$0	–	-131,981	-100.0%	-0.04%	–
ALT	Exit	ALTIMMUNE INCcall	$0	–	-100,000	-100.0%	-0.04%	–
IDYA	Exit	IDEAYA BIOSCIENCES INC	$0	–	-60,744	-100.0%	-0.04%	–
HCIIU	Exit	HUDSON EXECUTIVE INVS CORP Iunit 01/31/2027	$0	–	-150,000	-100.0%	-0.04%	–
FULC	Exit	FULCRUM THERAPEUTICS INC	$0	–	-126,068	-100.0%	-0.04%	–
HIIIU	Exit	HUDSON EXECUTIVE INVES IIIunit 02/22/2026	$0	–	-150,000	-100.0%	-0.04%	–
RCUS	Exit	ARCUS BIOSCIENCES INCcall	$0	–	-56,900	-100.0%	-0.05%	–
CGEN	Exit	COMPUGEN LTDcall	$0	–	-198,400	-100.0%	-0.05%	–
AMWL	Exit	AMERICAN WELL CORPput	$0	–	-100,000	-100.0%	-0.05%	–
INO	Exit	INOVIO PHARMACEUTICALS INCcall	$0	–	-200,000	-100.0%	-0.05%	–
AFMD	Exit	AFFIMED N V	$0	–	-240,542	-100.0%	-0.05%	–
NVTA	Exit	INVITAE CORPput	$0	–	-50,000	-100.0%	-0.05%	–
MGNX	Exit	MACROGENICS INC	$0	–	-68,792	-100.0%	-0.06%	–
VRTX	Exit	VERTEX PHARMACEUTICALS INC	$0	–	-10,243	-100.0%	-0.06%	–
FREQ	Exit	FREQUENCY THERAPEUTICS INCput	$0	–	-250,000	-100.0%	-0.07%	–
VXRT	Exit	VAXART INCcall	$0	–	-401,500	-100.0%	-0.07%	–
ACAD	Exit	ACADIA PHARMACEUTICALS INCput	$0	–	-100,000	-100.0%	-0.07%	–
BFLY	Exit	BUTTERFLY NETWORK INC	$0	–	-183,765	-100.0%	-0.09%	–
GILD	Exit	GILEAD SCIENCES INC	$0	–	-50,602	-100.0%	-0.09%	–
ATRC	Exit	ATRICURE INCcall	$0	–	-49,800	-100.0%	-0.09%	–
CFMS	Exit	CONFORMIS INC	$0	–	-3,396,043	-100.0%	-0.10%	–
BFLYWS	Exit	BUTTERFLY NETWORK INC*w exp 05/27/202	$0	–	-533,372	-100.0%	-0.10%	–
MRNA	Exit	MODERNA INC	$0	–	-26,791	-100.0%	-0.10%	–
EXAS	Exit	EXACT SCIENCES CORPput	$0	–	-30,000	-100.0%	-0.11%	–
ARYA	Exit	ARYA SCIENCES ACQUISITION CO	$0	–	-295,554	-100.0%	-0.12%	–
NNOX	Exit	NANO X IMAGING LTDput	$0	–	-100,000	-100.0%	-0.12%	–
SOLY	Exit	SOLITON INC	$0	–	-237,650	-100.0%	-0.12%	–
ACRS	Exit	ACLARIS THERAPEUTICS INC	$0	–	-175,799	-100.0%	-0.13%	–
LSAQ	Exit	LIFESCI ACQUISITION II CORP	$0	–	-438,111	-100.0%	-0.13%	–
DFHT	Exit	DEERFIELD HEALTHCARE TECH AC	$0	–	-367,014	-100.0%	-0.13%	–
DCPH	Exit	DECIPHERA PHARMACEUTICALS INcall	$0	–	-101,200	-100.0%	-0.13%	–
HGEN	Exit	HUMANIGEN INCcall	$0	–	-245,300	-100.0%	-0.13%	–
CDNA	Exit	CAREDX INCput	$0	–	-70,000	-100.0%	-0.14%	–
XENT	Exit	INTERSECT ENT INCcall	$0	–	-256,800	-100.0%	-0.15%	–
ITMR	Exit	ITAMAR MED LTDsponsored ads	$0	–	-227,751	-100.0%	-0.16%	–
MGNX	Exit	MACROGENICS INCcall	$0	–	-175,000	-100.0%	-0.16%	–
FOLD	Exit	AMICUS THERAPEUTICS INCcall	$0	–	-622,500	-100.0%	-0.18%	–
TMDX	Exit	TRANSMEDICS GROUP INCput	$0	–	-150,000	-100.0%	-0.18%	–
TNDM	Exit	TANDEM DIABETES CARE INCput	$0	–	-70,800	-100.0%	-0.18%	–
HGEN	Exit	HUMANIGEN INCput	$0	–	-340,200	-100.0%	-0.18%	–
INNV	Exit	INNOVAGE HLDG CORP	$0	–	-251,225	-100.0%	-0.18%	–
MRNA	Exit	MODERNA INCput	$0	–	-50,600	-100.0%	-0.19%	–
CRIS	Exit	CURIS INCcall	$0	–	-597,200	-100.0%	-0.19%	–
	Exit	DARIOHEALTH CORP	$0	–	-374,707	-100.0%	-0.20%	–
KRA	Exit	KRATON CORPORATIONcall	$0	–	-202,500	-100.0%	-0.21%	–
HOLX	Exit	HOLOGIC INCput	$0	–	-100,000	-100.0%	-0.21%	–
ABCL	Exit	ABCELLERA BIOLOGICS INC	$0	–	-225,000	-100.0%	-0.22%	–
CYRX	Exit	CRYOPORT INCput	$0	–	-147,800	-100.0%	-0.22%	–
MRK	Exit	MERCK & CO. INCcall	$0	–	-100,000	-100.0%	-0.22%	–
ZBH	Exit	ZIMMER BIOMET HOLDINGS INCcall	$0	–	-49,800	-100.0%	-0.23%	–
HEC	Exit	HUDSON EXECUTIVE INVT CORP	$0	–	-808,089	-100.0%	-0.23%	–
OCDX	Exit	ORTHO CLINICAL DIAGNOSTICS H	$0	–	-413,891	-100.0%	-0.23%	–
TFX	Exit	TELEFLEX INCORPORATEDput	$0	–	-20,000	-100.0%	-0.24%	–
COO	Exit	COOPER COS INC	$0	–	-21,646	-100.0%	-0.24%	–
PKI	Exit	PERKINELMER INCput	$0	–	-65,000	-100.0%	-0.24%	–
MRVI	Exit	MARAVAI LIFESCIENCES HLDGS I	$0	–	-236,350	-100.0%	-0.24%	–
CNMD	Exit	CONMED CORP	$0	–	-65,000	-100.0%	-0.24%	–
CRL	Exit	CHARLES RIV LABS INTL INCput	$0	–	-30,000	-100.0%	-0.25%	–
INOV	Exit	INOVALON HLDGS INCcall	$0	–	-303,500	-100.0%	-0.25%	–
INCY	Exit	INCYTE CORP	$0	–	-110,750	-100.0%	-0.26%	–
NARI	Exit	INARI MED INC	$0	–	-85,000	-100.0%	-0.26%	–
TMO	Exit	THERMO FISHER SCIENTIFIC INCput	$0	–	-20,000	-100.0%	-0.26%	–
ICUI	Exit	ICU MED INCcall	$0	–	-47,800	-100.0%	-0.28%	–
SGFY	Exit	SIGNIFY HEALTH INC	$0	–	-345,757	-100.0%	-0.29%	–
FLGT	Exit	FULGENT GENETICS INCput	$0	–	-110,000	-100.0%	-0.30%	–
CSTL	Exit	CASTLE BIOSCIENCES INCput	$0	–	-156,000	-100.0%	-0.30%	–
IART	Exit	INTEGRA LIFESCIENCES HLDGS Cput	$0	–	-165,400	-100.0%	-0.33%	–
NVST	Exit	ENVISTA HOLDINGS CORPORATION	$0	–	-283,176	-100.0%	-0.33%	–
	Exit	DERMTECH INC	$0	–	-245,306	-100.0%	-0.36%	–
JWS	Exit	JAWS ACQUISITION CORP	$0	–	-1,047,466	-100.0%	-0.40%	–
EAR	Exit	EARGO INCput	$0	–	-304,800	-100.0%	-0.43%	–
NTLA	Exit	INTELLIA THERAPEUTICS INCcall	$0	–	-198,300	-100.0%	-0.45%	–
COO	Exit	COOPER COS INCcall	$0	–	-45,500	-100.0%	-0.50%	–
SIBN	Exit	SI BONE INC	$0	–	-550,104	-100.0%	-0.50%	–
MDT	Exit	MEDTRONIC PLCput	$0	–	-150,000	-100.0%	-0.50%	–
ABT	Exit	ABBOTT LABSput	$0	–	-150,000	-100.0%	-0.51%	–
ALGN	Exit	ALIGN TECHNOLOGY INC	$0	–	-35,000	-100.0%	-0.54%	–
VCEL	Exit	VERICEL CORP	$0	–	-374,435	-100.0%	-0.59%	–
ALXN	Exit	ALEXION PHARMACEUTICALS INC	$0	–	-156,581	-100.0%	-0.68%	–
ILMN	Exit	ILLUMINA INCput	$0	–	-62,500	-100.0%	-0.68%	–
DXCM	Exit	DEXCOM INCput	$0	–	-67,500	-100.0%	-0.69%	–
UNH	Exit	UNITEDHEALTH GROUP INCput	$0	–	-75,000	-100.0%	-0.80%	–
PPH	Exit	VANECK VECTORS ETF TRput	$0	–	-550,000	-100.0%	-1.08%	–
CI	Exit	CIGNA CORP NEWput	$0	–	-160,000	-100.0%	-1.10%	–
FXH	Exit	FIRST TR EXCHANGE TRADED FDput	$0	–	-402,000	-100.0%	-1.24%	–
MCK	Exit	MCKESSON CORPput	$0	–	-225,000	-100.0%	-1.25%	–
IBB	Exit	ISHARES TRput	$0	–	-350,000	-100.0%	-1.50%	–
ARKG	Exit	ARK ETF TRput	$0	–	-700,000	-100.0%	-1.77%	–
ARKK	Exit	ARK ETF TRput	$0	–	-622,500	-100.0%	-2.13%	–
XLV	Exit	SELECT SECTOR SPDR TRput	$0	–	-1,000,000	-100.0%	-3.33%	–
XBI	Exit	SPDR SER TRput	$0	–	-1,650,000	-100.0%	-6.38%	–
IWM	Exit	ISHARES TRput	$0	–	-1,392,500	-100.0%	-8.77%	–
SPY	Exit	SPDR S&P 500 ETF TRput	$0	–	-850,000	-100.0%	-9.60%	–
QQQ	Exit	INVESCO QQQ TRput	$0	–	-1,075,000	-100.0%	-9.78%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2021-08-16

Signatures

The EDGAR filing(s) were signed by:

Alyssa Romano — Chief Financial Officer and Chief Compliance Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
ICU MED INC	26	Q2 2023	4.2%
NANOSTRING TECHNOLOGIES INC	26	Q2 2023	3.3%
VIEWRAY INC	25	Q2 2023	3.2%
LIVANOVA PLC	23	Q3 2023	3.8%
ALEXION PHARMACEUTICALS INC	23	Q1 2021	4.3%
INSPIRE MED SYS INC	22	Q3 2023	3.7%
BOSTON SCIENTIFIC CORP	22	Q3 2022	4.8%
INVACARE CORP	22	Q3 2021	2.8%
ESTABLISHMENT LABS HLDGS INC	21	Q3 2023	5.0%
INTERSECT ENT INC	21	Q2 2021	2.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

PURA VIDA INVESTMENTS, LLC Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Stryve Foods Holdings, LLC	April 19, 2023	1,470,649	5.6%
ICAD INC	March 15, 2023	1,277,214	5.0%
ESTABLISHMENT LABS HOLDINGS INC.	February 14, 2023	1,002,767	4.1%
Pulmonx Corp	February 14, 2023	1,216,258	3.2%
Quotient Ltd^{Sold out}	February 14, 2023	0	0.0%
Universe Pharmaceuticals INC^{Sold out}	February 14, 2023	0	0.0%
MedMen Enterprises, Inc.	April 29, 2022	139,755,072	21.4%
INVACARE CORP^{Sold out}	February 14, 2022	0	0.0%
MedAvail Holdings, Inc.	February 14, 2022	714,120	2.2%
TELA Bio, Inc.	February 14, 2022	564,120	3.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings

Type	Filed
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
13F-HR	2024-02-13
SC 13D/A	2023-12-29

View PURA VIDA INVESTMENTS, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

The reported total value is incorrect (3213019000.0 != 3213023000.0)

Export PURA VIDA INVESTMENTS, LLC's holdings